Abstract:Aim: This prospective multicenter randomized controlled clinical trial was designed to compare the clinical outcomes of papilla preservation flap surgery with or without the application of enamel matrix derivatives (EMD). This article reports on early healing events, post-operative morbidity and patient perceptions of the surgical outcomes. Material and Methods: One hundred and seventy-two patients with advanced chronic periodontitis and at least one intrabony defect of greater than or equal to3 mm were recruited in 12 centres in seven countries (European Research Group on Periodontology (ERGOPERIO)). Papilla preservation flaps were used to obtain access and primary closure. After debridement, and root conditioning, EMD was applied in the test subjects, and omitted in the controls. Healing was monitored 1, 2, 3, 4, 6 and 12 weeks after surgery. During the first 12 weeks of healing, supracrestal soft-tissue density was evaluated with a computer-assisted densitometric image analysis system (CADIA) using underexposed radiographs taken on a subset of 34 patients. Patient perceptions were evaluated with a questionnaire immediately after the procedure, at suture removal 1 week later and at 1 year. Results: Subjects reported little intraoperative or post-operative pain or discomfort for both test and controls. Twenty-four percent of controls and 30% of tests (p=0.64) reported a degree of interference with daily activities for an average of 3 and 3.5 days, respectively. Post-surgical edema was noted in 25% of tests and 28% of controls. Wound dehiscence in the interdental portion of the flap was uncommon (14% of tests and 12% of controls at week 1) and of limited size. Root sensitivity was the most frequent post-operative adverse event: it affected 45% of test and 35% of controls (p=0.55). Up to 6 weeks post-operatively, soft-tissue densities were significantly higher in subjects treated with EMD with respect to controls. One year after completion of the surgery, patients reported high levels of satisfaction with the outcomes. The most frequently reported benefits included the ability to preserve a tooth/dentition and to maintain/improve chewing ability. The cost and need for frequent follow-ups were cited as significant drawbacks. Conclusions: This study portrayed the early healing events, pain, discomfort and adverse events of papilla preservation flap surgery and the 1-year patient perceptions of the benefits and disadvantages of periodontal surgery in intrabony defects. Earlier gains in soft-tissue density were observed following application of EMD. In terms of patient-centered outcomes, however, both procedures performed in a similar manner.

Treatment of periodontal defects with enamel matrix derivative: clinical evaluation at early healing stages

Treatment of intrabony periodontal defects with enamel matrix derivative in private practice: a long-term retrospective study

The use of enamel matrix derivative alone versus in combination with bone grafts to treat patients with periodontal intrabony defects: a meta-analysis.

Enamel matrix proteins in the treatment of intra-bony defects. A prospective 24-month clinical trial

Healing of two and three wall intrabony periodontal defects following treatment with an enamel matrix derivative combined with autogenous bone

Enamel Matrix Proteins in the Regenerative Therapy of Deep Intrabony Defects

Enamel Matrix Proteins In The Regenerative Therapy Of Deep Intrabony Defects - A Multicentre Randomized Controlled Clinical Trial

Periodontal regeneration with enamel matrix derivative in reconstructive periodontal therapy: a systematic review

Ten-year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a β-tricalcium phosphate

Enamel matrix derivative versus bioactive ceramic filler in the treatment of intrabony defects: 12-month results

Baseline radiographic defect angle of the intrabony defect as a prognostic indicator in regenerative periodontal surgery with enamel matrix derivative

Healing, post-operative morbidity and patient perception of outcomes following regenerative therapy of deep intrabony defects.

Effect of EDTA root conditioning on the healing of intrabony defects treated with an enamel matrix protein derivative

Local Application Of Enamel Matrix Derivative Prevents Acute Systemic Inflammation After Periodontal Regenerative Surgery: A Randomized Controlled Clinical Trial

Microsurgical access flap and enamel matrix derivative for the treatment of periodontal intrabony defects: a controlled clinical study

Clinical outcomes after treatment of non-contained intrabony defects with enamel matrix derivative or guided tissue regeneration: a 12-month randomized controlled clinical trial

Four-year results following treatment of intrabony periodontal defects with an enamel matrix derivative alone or combined with a biphasic calcium phosphate

Five years clinical results following treatment of human intra-bony defects with an enamel matrix derivative: a randomized controlled trial

Evaluation of efficacy of enamel matrix derivative in the treatment of intrabony defects: a 24-month multicenter study

Does Enamel Matrix Derivative Application Provide Additional Clinical Benefits in Residual Periodontal Pockets Associated with Suprabony Defects? A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Enamel matrix derivative stabilizes blood clot and improves clinical healing in deep pockets after flapless periodontal therapy: A Randomized Clinical Trial